Vincorion Adds Workers and Capacity as Free Cash Flow Turns Negative; Record Backlog Offers Little Comfort for Stock

Vincorion expands capacity for European rearmament; €1.2B order backlog supports growth. Free cash flow negative due to capex and working capital; share price volatile amid tight float.

The defense contractor Vincorion is hiring at a steady clip and pouring money into new production lines, reacting to a wave of European rearmament that stretches far beyond the Bundeswehr’s €100 billion special fund. Chief executive Kajetan von Mentzingen describes the expansion not as a one-off program but as the new normal. The Wedel-based company already employs more than 900 people, and the CEO expects headcount to rise by 5% to 6% a year for the foreseeable future.

That operational push is backed by an order book that speaks for itself. First-quarter order intake reached €149 million, pushing the total backlog to roughly €1.2 billion. With over 90% of the planned 2026 revenue already under contract, the company looks well-positioned for the years ahead. First-quarter revenue came in at about €69 million, while adjusted EBIT jumped 30% to €12.4 million.

But the financial statements tell a more mixed story. Free cash flow swung from a positive €1.6 million a year ago to minus €7.1 million in the first quarter, squeezed by higher capital expenditure, a working-capital build?up, and tax payments. Management stresses these are temporary drags and still targets operating cash flow of around €38 million for the full year.

The capacity expansion is central to the growth plan. New production lines are being installed at sites in Altenstadt, Essen, Wedel and in the United States. Crucially, the company intends to fund the investment out of its own cash flow, ruling out an equity raise or additional debt. For shareholders, that means near-term cash flow will remain under pressure even as orders pile up.

For 2026, Vincorion reaffirmed its revenue target of €280 million to €320 million, with an adjusted EBIT margin of 18% to 19%. The medium-term ambitions are even more aggressive: over 15% annual revenue growth and a 20% adjusted EBIT margin.

The share price, however, has struggled to reflect that trajectory. On one recent Friday the stock closed at €18.46, down 13% for the week, with the relative strength index at 22.1 signalling oversold conditions. A subsequent session saw it inch up 0.65% to €18.58, but that still left a weekly loss of 12.44%. Over the past month the stock is up about 17% — one calculation puts the gain at 17.06%, another at 17.82% — yet the annualised volatility of nearly 71% illustrates just how quickly momentum can turn.

Contributing to the wild swings is the tight shareholder structure. Private equity firm STAR Capital holds 47.5% of the shares and is locked in until autumn 2026. With such a large block tied up, the free float is thin, magnifying price moves on any change in sentiment. When the lock-up expires, a substantial block could hit a market with limited demand, a risk that is never far from investors’ minds.

For now, the focus is on cash conversion. The company is adding staff and capacity at a pace that absorbs cash, but the record backlog gives it a long runway to turn orders into revenue and profit. Whether the stock can break out of its volatile pattern will depend less on the order inflow and more on how quickly that inflow becomes free cash flow.